Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-17 Purchase |
2023-11-21 12:19 pm |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
25,000 | $1.09 | $27,250 | 79,000 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-20 10:07 am |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
50,000 | $0.9399 | $46,995 | 54,000 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-17 12:37 pm |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
150,000 | $0.9198 | $137,970 | 186,496 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-17 12:36 pm |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
85,000 | $0.8894 | $75,599 | 85,000 (Direct) |
View |
| 2023-07-21 Purchase |
2023-07-25 4:22 pm |
HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director |
2,486,744 | $1.37 | $3,406,839 | 8,187,514 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-19 Option Award |
2024-01-19 9:02 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
97,633 | $0 | 152,915 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:01 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
47,924 | $0 | 47,924 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:01 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
433,924 | $0 | 433,924 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:00 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
433,924 | $0 | 433,924 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 8:58 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
1,545,252 | $0 | 1,545,252 (Direct) |
View |
| 2024-01-13 Tax Withholding |
2024-01-16 5:19 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
756 | $2.15 | 64,238 (Direct) |
View |
| 2024-01-13 Exercise |
2024-01-16 5:19 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
1,841 | $0 | 64,238 (Direct) |
View |
| 2023-07-25 Tax Withholding |
2023-10-17 7:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
14,743 | $1.51 | 64,994 (Direct) |
View |
| 2023-10-13 Tax Withholding |
2023-10-17 7:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
860 | $0.72 | 64,994 (Direct) |
View |
| 2023-07-25 Exercise |
2023-10-17 7:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
45,115 | $0 | 64,994 (Direct) |
View |
| 2023-08-22 Tax Withholding |
2023-08-24 4:09 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
692 | $1.65 | 36,496 (Direct) |
View |
Ownership |
2023-07-25 4:15 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim 10% Owner |
0 | $0 | 26,713,503 (Indirect) |
View |
| 2023-07-17 Option Award |
2023-07-19 6:21 pm |
N/A 2033-07-17 |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-07-13 Exercise |
2023-07-17 5:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 63,376 (Direct) |
View |
| 2023-07-13 Tax Withholding |
2023-07-17 5:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $1.31 | 63,376 (Direct) |
View |
| 2023-07-13 Exercise |
2023-07-17 5:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,485 | $0 | 37,966 (Direct) |
View |
| 2023-07-13 Tax Withholding |
2023-07-17 5:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
860 | $1.31 | 37,966 (Direct) |
View |
Ownership |
2023-06-23 4:28 pm |
N/A 2033-06-16 |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
0 | $0 | 1,350,000 (Direct) |
View |
Ownership |
2023-06-12 4:41 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
0 | $0 | 1,254,000 (Direct) |
View |
| 2023-05-22 Tax Withholding |
2023-05-24 5:04 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
691 | $1.45 | 37,188 (Direct) |
View |
| 2023-04-13 Tax Withholding |
2023-04-17 5:28 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $2.88 | 65,388 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 5:28 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 65,388 (Direct) |
View |
| 2023-04-13 Tax Withholding |
2023-04-17 5:27 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
2,012 | $2.88 | 82,084 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 5:27 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
5,814 | $0 | 82,084 (Direct) |
View |
| 2023-04-13 Tax Withholding |
2023-04-17 5:27 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
860 | $2.88 | 38,826 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 5:27 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,484 | $0 | 38,826 (Direct) |
View |
| 2023-04-13 Tax Withholding |
2023-04-17 5:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,417 | $2.88 | 63,766 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 5:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 63,766 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:10 pm |
N/A 2033-04-03 |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
7,500,000 | $0 | 7,500,000 (Direct) |
View |
Ownership |
2023-03-02 4:13 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | KOTLER KEVIN Director |
0 | $0 | 805,151 (Direct) |
View |
Ownership |
2023-03-02 4:11 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Director |
0 | $0 | 265,151 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 7:20 pm |
N/A 2033-02-22 |
HERON THERAPEUTICS INC. | HRTX | Morgan Adam See Notes 2 & 3 |
265,151 | $0 | 4,765,151 (Direct) |
View |
Ownership |
2023-02-08 6:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam See Footnote 2 |
0 | $0 | 4,500,000 (Indirect) |
View |
Ownership |
2023-02-08 6:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim See Footnote 1 |
0 | $0 | 11,750,000 (Indirect) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:10 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
49,788 | $0 | 49,788 (Direct) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:10 pm |
N/A 2033-01-18 |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
850,000 | $0 | 850,000 (Direct) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:09 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
66,385 | $0 | 66,385 (Direct) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:09 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
42,631 | $0 | 42,631 (Direct) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
149,365 | $0 | 149,365 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:37 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
2,012 | $3.17 | 69,054 (Direct) |
View |
| 2022-10-31 Other |
2023-01-17 5:37 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,654 | $3.2725 | 69,054 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:37 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
5,814 | $0 | 69,054 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $3.17 | 319,972 (Direct) |
View |
| 2022-10-31 Other |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,655 | $3.2725 | 319,972 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,767 | $0 | 319,972 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
2,012 | $3.17 | 84,096 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
5,814 | $0 | 84,096 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:35 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
1,013 | $3.17 | 39,686 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:35 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
2,485 | $0 | 39,686 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $3.17 | 66,838 (Direct) |
View |
| 2022-10-31 Other |
2023-01-17 5:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,655 | $3.2725 | 66,838 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 66,838 (Direct) |
View |